Detoxication of carcinogenic fjord-region diol epoxides of polycyclic aromatic hydrocarbons by glutathione transferase P1-1 variants and glutathione

FEBS Letters

Volumn 438, Issue 3, 1998, Pages 206-210

  Sundberg, Kathrin ^a   Seidel, Albrecht ^b   Mannervik, Bengt ^c   Jernström, Bengt ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Carcinogenesis; Diol epoxide; Fjord region; Glutathione conjugation; Human glutathione transferase P1 1; Polycyclic aromatic hydrocarbon

Indexed keywords

DIOL EPOXIDE; GLUTATHIONE TRANSFERASE; POLYCYCLIC AROMATIC HYDROCARBON; UNCLASSIFIED DRUG;

ARTICLE; CANCER SUSCEPTIBILITY; DETOXIFICATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE FREQUENCY; HOMOZYGOSITY; HUMAN; PRIORITY JOURNAL;

CARCINOGENS; CATALYSIS; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMANS; KINETICS; METABOLIC DETOXICATION, DRUG; MOLECULAR STRUCTURE; POLYCYCLIC HYDROCARBONS, AROMATIC; STRUCTURE-ACTIVITY RELATIONSHIP; VARIATION (GENETICS);

FELIS CATUS;

EID: 0031767266     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(98)01291-5     Document Type: Article

References (36)

1. Sims P., Grover P.L. Adv. Cancer Res. 20:1974;165-275.
2. Dipple, A. (1985) in: Polycyclic Hydrocarbons and Carcinogenesis (Harvey, R.G., Ed.) ACS Symposium Series 283, pp. 1-17, American Chemical Society, Washington, DC.
3. Thakker, D.R., Yagi, H., Levin, W., Wood, A.W., Conney, A.H. and Jerina, D.M. (1985) in: Bioactivation of Foreign Compounds (Anders, M.W., Ed.), pp. 177-242, Academic Press, New York.
4. Jerina, D.M., Chadha, A., Cheh, A.M., Schurdak, M.E., Wood, A.W. and Sayer, J.M. (1991) in: Biological Reactive Intermediates (Witmer, C.M., Snyder, R., Jollow, D.J., Kalf, G.S., Kocsis, J.J. and Sipes, I.G., Eds.), pp. 533-553, Plenum Press, New York.
5. Harvey, R.G. (1991) Polycyclic Aromatic Hydrocarbons: Chemistry and Carcinogenicity, Cambridge University Press, Cambridge.
6. Amin S., Krzeminski J., Rivenson A., Kurtzke C., Hecht S.S., Elbayoumy K. Carcinogenesis. 16:1995;1971-1974.
7. Dipple A., Pigott M.A., Agarwal S.K., Yagi H., Sayer J.M., Jerina D.M. Nature. 327:1987;535-536.
8. Szeliga J., Page J.E., Hilton B.D., Kiselyov A.S., Harvey R.G., Dunayevskiy Y.M., Vouros P., Dipple A. Chem. Res. Toxicol. 8:1995;1014-1019.
9. Glatt H., Piee A., Pauly K., Steinbrecher T., Schrode R., Oesch F., Seidel A. Cancer Res. 51:1991;1659-1667.
10. Levin W., Chang R.L., Wood A.W., Thakker D.R., Yagi H., Jerina D.M., Conney A.H. Cancer Res. 46:1986;2257-2261.
11. Townsend A.J., Fields W.R., Haynes R.L., Doss A.J., Li Y., Doehmer J., Morrow C.S. Chem. Biol. Interact. 112:1998;389-407.
12. Moscow J.A., Townsend A.J., Cowan K.H. Mol. Pharmacol. 36:1989;22-28.
13. Robertson I.G., Guthenberg B., Mannervik B., Jernström B. Cancer Res. 46:1986;2220-2224.
14. Hendersson C.J., Smith A.G., Ure J., Brown K., Bacon E.J., Wolf C.R. Proc. Natl. Acad. Sci. USA. 95:1998;5275-5280.
15. Harries L.W., Stubbins M.J., Forman D., Howard G.C.W., Wolf C.R. Carcinogenesis. 18:1997;641-644.
16. Matthias C., Bockmühl U., Jahnke V., Harries L.W., Wolf C.R., Jones P.W., Alldersea J., Worrall S.F., Hand P., Fryer A.A., Strange R.C. Pharmacogenetics. 8:1998;1-6.
17. Harris M.J., Coggan M., Langton L., Wilson S.R., Board P.G. Pharmacogenetics. 8:1998;27-31.
18. Hu X., O'Donell R., Srivastava S.K., Xia H., Zimniak P., Nanduri B., Bleicher R.J., Awasthi S., Awasthi Y.C., Ji X., Singh S.V. Biochem. Biophys. Res. Commun. 235:1997;424-428.
19. Sundberg K., Johansson A.-S., Stenberg G., Widersten M., Seidel A., Mannervik B., Jernström B. Carcinogenesis. 19:1998;433-436.
20. Cavalieri E.L., Higginbotham S., RamaKrishna N.V.S., Devanesan P.D., Todorovic R., Rogan E.G., Salmasi S. Carcinogenesis. 12:1991;1939-1944.
21. Higginbotham S., RamaKrishna N.V.S., Johansson S.L., Rogan E.G., Cavalieri E.L. Carcinogenesis. 14:1993;875-878.
22. Jernström B., Funk M., Frank H., Mannervik B., Seidel A. Carcinogenesis. 17:1996;1491-1498.
23. Luch A., Glatt H.R., Platt K.L., Oesch F., Seidel A. Carcinogenesis. 15:1994;2507-2516.
24. Frank H., Luch A., Oesch F., Seidel A. Polycyclic Aromatic Compounds. 10:1996;109-116.
25. Jernström B., Seidel A., Funk M., Oesch F., Mannervik B. Carcinogenesis. 13:1992;1549-1555.
26. Board P.G., Webb G.C., Coggan M. Ann. Hum. Genet. 53:1989;205-213.
27. Ahmad H., Wilson D.E., Fritz R.R., Singh S.V., Medh R.D., Nagle G.T., Awasthi Y.C., Kurosky A. Arch. Biochem. Biophys. 278:1990;398-408.
28. Zimniak P., Nanduri B., Pikula S., Bandorowicz-Pikula J., Singhal S.S., Srivastava S.K., Awasthi S., Awasthi Y.C. Eur. J. Biochem. 224:1994;893-899.
29. Ali-Osman F., Akande O., Antoun G., Mao J.-X., Buolamwini J. J. Biol. Chem. 272:1997;10004-10012.
30. Cameron A.D., Sinning I., L'Hermit G., Olin B., Board P.G., Mannervik B., Jones T.A. Structure. 3:1995;717-727.
31. Hu X., Xia H., Srivastava S.K., Herzog C., Awasthi Y.C., Ji X., Zimniak P., Singh S.V. Biochem. Biophys. Res. Commun. 238:1997;397-402.
32. Sundberg K., Widersten M., Seidel A., Mannervik B., Jernström B. Chem. Res. Toxicol. 10:1997;1221-1227.
33. Wood A.W., Chang R.L., Levin W., Thakker D.R., Yagi H., Sayer J.M., Jerina D.M., Conney A.H. Cancer Res. 44:1984;2320-2324.
34. IARC (1985) IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 35, Polycyclic Aromatic Hydrocarbons, International Agency for Research on Cancer, Lyon.
35. Kadlubar, F. (1996) Polymorphisms involved in the bioactivation and detoxification of aromatic and heterocyclic amine carcinogens. Meeting Abstract No. 10, 7th North American ISSX Meeting, San Diego, CA.
36. Ryberg D., Skaug V., Hewer A., Phillips D.H., Harries L.W., Wolf C.R., Ogreid D., Ulvik A., Vu P., Haugen A. Carcinogenesis. 18:1997;1285-1289.